MP

Matt Pando, PhD

Founder, CEO & President

Recognify Life Sciences

Therapeutic Areas

Recognify Life Sciences Pipeline

DrugIndicationPhase
RL-007Cognitive Impairment Associated with Schizophrenia (CIAS)Phase 2